Jul 13, 2016 9:00 AM
The National Cancer Institute’s (NCI) Cancer Clinical Investigator Team Leadership Awards recognize and support outstanding clinical investigators at NCI-Designated Cancer Centers who participate extensively in NCI- funded collaborative clinical trials and whose leadership, participation, and activities promote a culture of successful clinical research. Established in 2009, the awards are intended to help retain investigators in academic clinical research careers. This year, 13 investigators nationwide, including Theresa Werner, MD, Huntsman Cancer Institute (HCI) investigator and University of Utah assistant professor of medicine have received the award. Each of these investigators is a full-time faculty member who is a board- certified physician and has practiced medicine between 3 and 10 years post-fellowship. The 2016 awardees were formally announced at the NCI Clinical Trials and Translational Research Advisory Committee Meeting on Wednesday, July 13, 2016.
Each recipient was nominated for the award by his/her Cancer Center Director on the basis of qualifications, interests, accomplishments, and motivation, and based upon the nominee's intent and ability to promote a successful clinical research culture and to pursue an academic career in clinical research. The recipients will devote 15 to 20 percent effort to the activities associated with this award, and the sponsoring Cancer Centers have agreed to protect the awardees’ time for these activities. The award provides partial salary support for 2 years for the recipient to engage in activities and efforts related to the award. The recipients for 2016 include:
Rahul Aggarwal, M.D.
UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco
Jamie N. Bakkum-Gamez, M.D.
Mayo Clinic Cancer Center
Catherine S. M. Diefenbach, M.D.
Perlmutter Cancer Center, New York University Langone Medical Center
Noah M. Hahn, M.D.
Sidney Kimmel Cancer Center, Johns Hopkins University
Erin W. Hofstatter, M.D.
Yale Cancer Center, Yale School of Medicine
Kevin R. Kelly, M.D., Ph.D.
USC Norris Comprehensive Cancer Center, University of Southern California
Sarah E. S. Leary, M.D., M.S.
Fred Hutchinson Cancer Research Center
Fred Hutchinson/University of Washington Cancer Consortium
Frederick L. Locke, M.D.
Moffitt Cancer Center and Research Institute, Inc.
Rachel Miller, M.D.
Markey Cancer Center, University of Kentucky
Taofeek K. Owonikoko, M.D., Ph.D.
Winship Cancer Institute, Emory University
Geoffrey R. Oxnard, M.D.
Dana-Farber/Harvard Cancer Center, Dana-Farber Cancer Institute
Dale R. Shepard, M.D., Ph.D.
Case Comprehensive Cancer Center, Case Western Reserve University
Theresa L. Werner, M.D.
Huntsman Cancer Institute, University of Utah
“The NCI is pleased to recognize these talented investigators who dedicate themselves to the conduct of cancer clinical trials,” said Dr. Sheila Prindiville, director of NCI’s Coordinating Center for Clinical Trials. “These awardees have outstanding leadership skills in cancer clinical trial activities and will be conducting research to advance medical care in several different cancer types, including small cell lung cancer, a recalcitrant tumor.”
To learn more about this award visit: http://www.cancer.gov/about-nci/organization/ccct/other- programs/ccitla